Michael D Brundage1, Katherine C Smith2,3, Emily A Little4, Elissa T Bantug2, Claire F Snyder2,3,4. 1. Queen's Cancer Research Institute, Queen's University, 10 Stuart St, Level 2, Kingston, ON, K7L 3N6, Canada. michael.brundage@krcc.on.ca. 2. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans St, Baltimore, MD, 21287, USA. 3. Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA. 4. Division of General Internal Medicine, Johns Hopkins School of Medicine, 624 N. Broadway, Baltimore, MD, 21205, USA.
Abstract
BACKGROUND: Patient-reported outcomes (PROs) promote patient-centered care by using PRO research results ("group-level data") to inform decision making and by monitoring individual patient's PROs ("individual-level data") to inform care. We investigated the interpretability of current PRO data presentation formats. METHOD: This cross-sectional mixed-methods study randomized purposively sampled cancer patients and clinicians to evaluate six group-data or four individual-data formats. A self-directed exercise assessed participants' interpretation accuracy and ratings of ease-of-understanding and usefulness (0 = least to 10 = most) of each format. Semi-structured qualitative interviews explored helpful and confusing format attributes. RESULTS: We reached thematic saturation with 50 patients (44 % < college graduate) and 20 clinicians. For group-level data, patients rated simple line graphs highest for ease-of-understanding and usefulness (median 8.0; 33 % selected for easiest to understand/most useful) and clinicians rated simple line graphs highest for ease-of-understanding and usefulness (median 9.0, 8.5) but most often selected line graphs with confidence limits or norms (30 % for each format for easiest to understand/most useful). Qualitative results support that clinicians value confidence intervals, norms, and p values, but patients find them confusing. For individual-level data, both patients and clinicians rated line graphs highest for ease-of-understanding (median 8.0 patients, 8.5 clinicians) and usefulness (median 8.0, 9.0) and selected them as easiest to understand (50, 70 %) and most useful (62, 80 %). The qualitative interviews supported highlighting scores requiring clinical attention and providing reference values. CONCLUSIONS: This study has identified preferences and opportunities for improving on current formats for PRO presentation and will inform development of best practices for PRO presentation. Both patients and clinicians prefer line graphs across group-level data and individual-level data formats, but clinicians prefer greater detail (e.g., statistical details) for group-level data.
RCT Entities:
BACKGROUND:Patient-reported outcomes (PROs) promote patient-centered care by using PRO research results ("group-level data") to inform decision making and by monitoring individual patient's PROs ("individual-level data") to inform care. We investigated the interpretability of current PRO data presentation formats. METHOD: This cross-sectional mixed-methods study randomized purposively sampled cancerpatients and clinicians to evaluate six group-data or four individual-data formats. A self-directed exercise assessed participants' interpretation accuracy and ratings of ease-of-understanding and usefulness (0 = least to 10 = most) of each format. Semi-structured qualitative interviews explored helpful and confusing format attributes. RESULTS: We reached thematic saturation with 50 patients (44 % < college graduate) and 20 clinicians. For group-level data, patients rated simple line graphs highest for ease-of-understanding and usefulness (median 8.0; 33 % selected for easiest to understand/most useful) and clinicians rated simple line graphs highest for ease-of-understanding and usefulness (median 9.0, 8.5) but most often selected line graphs with confidence limits or norms (30 % for each format for easiest to understand/most useful). Qualitative results support that clinicians value confidence intervals, norms, and p values, but patients find them confusing. For individual-level data, both patients and clinicians rated line graphs highest for ease-of-understanding (median 8.0 patients, 8.5 clinicians) and usefulness (median 8.0, 9.0) and selected them as easiest to understand (50, 70 %) and most useful (62, 80 %). The qualitative interviews supported highlighting scores requiring clinical attention and providing reference values. CONCLUSIONS: This study has identified preferences and opportunities for improving on current formats for PRO presentation and will inform development of best practices for PRO presentation. Both patients and clinicians prefer line graphs across group-level data and individual-level data formats, but clinicians prefer greater detail (e.g., statistical details) for group-level data.
Authors: Deborah Watkins Bruner; Charlene J Bryan; Neil Aaronson; C Craig Blackmore; Michael Brundage; David Cella; Patricia A Ganz; Carolyn Gotay; Pamela S Hinds; Alice B Kornblith; Benjamin Movsas; Jeff Sloan; Lari Wenzel; Giles Whalen Journal: J Clin Oncol Date: 2007-11-10 Impact factor: 44.544
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Angus G K McNair; Sara T Brookes; Christopher R Davis; Miltiadis Argyropoulos; Jane M Blazeby Journal: J Clin Oncol Date: 2010-01-11 Impact factor: 44.544
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Gita Thanarajasingam; John P Leonard; Thomas E Witzig; Thomas M Habermann; Kristie A Blum; Nancy L Bartlett; Christopher R Flowers; Brandelyn N Pitcher; Sin-Ho Jung; Pamela J Atherton; Angelina Tan; Paul J Novotny; Amylou C Dueck Journal: Lancet Haematol Date: 2020-06 Impact factor: 18.959
Authors: Clifton O Bingham; Susan J Bartlett; Peter A Merkel; Thelma J Mielenz; Paul A Pilkonis; Lauren Edmundson; Emily Moore; Rajeev K Sabharwal Journal: Qual Life Res Date: 2016-02-25 Impact factor: 4.147
Authors: Katherine C Smith; Michael D Brundage; Elliott Tolbert; Emily A Little; Elissa T Bantug; Claire F Snyder Journal: Support Care Cancer Date: 2016-05-10 Impact factor: 3.603
Authors: Elliott Tolbert; Michael Brundage; Elissa Bantug; Amanda L Blackford; Katherine Smith; Claire Snyder Journal: Qual Life Res Date: 2018-11-29 Impact factor: 4.147
Authors: Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2016-09-19 Impact factor: 5.742
Authors: Marilyn M Schapira; Charu Aggarwal; Scott Akers; Jaya Aysola; Diana Imbert; Corey Langer; Charlie B Simone; Emily Strittmatter; Anil Vachani; Liana Fraenkel Journal: Ann Am Thorac Soc Date: 2016-11